including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use
If your expired pen has lost potency, you're essentially getting a lower dose, which could mean: Worsened blood sugar control if you have diabetes Less weight loss than expected A return of the symptoms that the medication was helping manage For people relying on semaglutide for diabetes management, this reduced effectiveness could be particularly dangerous
Most people tolerate it well
With personalized health coaching, body composition tracking, and ongoing physician oversight, Achieve members lose 20% or more of their body weight on average and keep it off